Tech News Iraq: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.

Press releases published on June 22, 2026

Jun. 22, 2026

Voice AI Startup Retell AI Earns No. 1 Spot on San Francisco Business Times' 2026 Best Places to Work in the Bay Area List

Indeterminate GlobeNewswire

Jun. 22, 2026

RelationalAI Recognized as One to Watch in Snowflake’s Modern Marketing Data Stack Report

Indeterminate GlobeNewswire

Jun. 22, 2026

iQor Opens New Cairo Delivery Hub, Expanding Global CX Reach Across EMEA and Beyond

Indeterminate GlobeNewswire

Jun. 22, 2026

ASICID Launches Plug-and-Play Crypto Miners With Up to $25,590 Monthly Revenue

Indeterminate GlobeNewswire

Jun. 22, 2026

ModelOp Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Governance Platforms

Indeterminate GlobeNewswire

Jun. 22, 2026

NVIDIA Vera Rubin Delivers World-Class Supercomputers for Science

Indeterminate GlobeNewswire

Jun. 22, 2026

Europe Unveils a Record 35 New NVIDIA AI Supercomputers

Indeterminate GlobeNewswire

Jun. 22, 2026

INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure

Indeterminate GlobeNewswire

Jun. 22, 2026

Introducing Agent Architect and Agent Performance Suite for Zoom Virtual Agent

Indeterminate GlobeNewswire

Jun. 22, 2026

SPARC AI Registered as AUKUS Authorised User, Opening Pathway to US and UK Defence Markets

Indeterminate GlobeNewswire

Jun. 22, 2026

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

Indeterminate GlobeNewswire

Jun. 22, 2026

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Indeterminate GlobeNewswire

Jun. 22, 2026

SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate

Indeterminate GlobeNewswire

Jun. 22, 2026

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

Jun. 22, 2026

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

Jun. 22, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

Jun. 22, 2026

Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 22, 2026

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Indeterminate GlobeNewswire

Jun. 22, 2026

EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer

Indeterminate GlobeNewswire

Jun. 22, 2026

Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care

Indeterminate GlobeNewswire